News | Thrombectomy Devices

March 8, 2016 — phenox GmbH announced participation in the SITS Open clinical trial, where pREset and pREset LITE ...

Home March 08, 2016
Home
News | Angiography

Fluoroscopy makes guiding a catheter through a blood vessel possible. However, fluoroscopy, a form of real-time moving X-ray, also exposes the patient to radiation. Now, a University of Missouri School of Medicine researcher has evaluated technology that may be used to replace fluoroscopy, eliminating the need for X-ray during cardiac ablation procedures.

Home March 08, 2016
Home
News | Stents Drug Eluting

Biotronik announced publication of results from the BIOSCIENCE trial in the journal EuroIntervention. The study’s authors suggest the Orsiro hybrid drug-eluting stent (DES) may have an advantage over Xience Prime/Xpedition in treating ST-segment elevation myocardial infarction (STEMI) patients. STEMI is a potentially fatal type of heart attack caused by a prolonged obstruction of blood supply in the heart. Every year nearly 250,000 people experience STEMI heart attacks.

Home March 07, 2016
Home
News | Heart Valve Technology

Women undergoing transcatheter aortic valve replacement (TAVR) have better survival rates than men at one year, according to a study published in Annals of Internal Medicine. These results are the opposite of those seen in surgical aortic valve replacement (SAVR), for which female sex has been shown to be associated with poorer outcomes.

Home March 07, 2016
Home
Technology | Stent Grafts

At the Houston Aortic Symposium, W. L. Gore & Associates, Inc. (Gore) announced the U.S. Food and Drug Administration (FDA) approval of the Gore Excluder Iliac Branch Endoprosthesis (IBE). The approval makes it the first off-the-shelf aortic branch device approved in the United States and the only device indicated for the endovascular treatment of common iliac artery aneurysms or aortoiliac aneurysms.

Home March 07, 2016
Home
News | Heart Valve Technology

Medtronic plc announced the first patients enrolled in the Evolut R FORWARD Clinical Study to evaluate performance outcomes using the CoreValve Evolut R System in everyday clinical practice.

Home March 07, 2016
Home
Technology | Leads Implantable Devices

March 4, 2016 — Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for the Acuity X4 ...

Home March 04, 2016
Home
News | Cath Lab

Recent results from the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) are evidence that stenting will continue to remain competitive with surgical treatment, said an analyst with research and consulting firm GlobalData. CREST data has shown patients with severe carotid artery stenosis suffered similar rates of adverse events in both stenting and endarterectomy procedures.

Home March 04, 2016
Home
Technology | Stent Grafts

W. L. Gore & Associates (Gore) announced the availability of a new 7.5 cm length of the Gore Viabahn Endoprosthesis with heparin bioactive surface. Gore developed this size in response to physician needs for certain clinical situations. The device is now available in six lengths: 2.5, 5, 7.5, 10, 15 and 25 cm.

Home March 04, 2016
Home
News | Stroke

Brain imaging may accurately identify patients likely to benefit from stroke clot removal instead of relying on the time since symptoms began as an indicator of treatment eligibility. The hypothesis was derived from research presented at the American Stroke Association's International Stroke Conference 2016.

Home March 04, 2016
Home
News | Congenital Heart

Last August, Children’s Hospital Los Angeles (CHLA) cardiologists confirmed the heart of a 27-week-old fetus suffered from a critical cardiac condition that prevented blood returning from the fetus’s lungs from circulating back into the body.

Home March 03, 2016
Home
Technology | Wearables

Vital Connect debuted the VitalPatch biosensor at the 2016 Healthcare Information and Management Systems Society (HIMSS) conference and exhibition, Feb. 29-March 4 in Las Vegas.

Home March 03, 2016
Home
Technology | Atherectomy Devices

Avinger Inc. announced the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for an enhanced version of its Pantheris lumivascular atherectomy system for the treatment of peripheral artery disease (PAD).

Home March 03, 2016
Home
Technology | Telecardiology

Philips announced four leading U.S. health systems have signed multi-year telehealth deals to implement the company’s remote intensive care unit (eICU) program.

Home March 03, 2016
Home
News | Clinical Decision Support

IBM Watson Health announced plans Feb. 18 to acquire Truven Health Analytics, a leading provider of cloud-based healthcare data, analytics and insights, for $2.6 billion. Truven will bring more than 8,500 clients, including U.S. federal and state government agencies, employers, health plans, hospitals, clinicians and life sciences companies, to the IBM Watson Health portfolio.

Home March 02, 2016
Home
Subscribe Now